# Long-term Follow-up of Fingolimod Phase II Study Patients

> **NCT02307838** · PHASE4 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 177 (actual)

## Conditions studied

- Multiple Sclerosis, Relapsing Forms of Multiple Sclerosis

## Interventions

- **OTHER:** Assessments arm

## Key facts

- **NCT ID:** NCT02307838
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 177 (ACTUAL)
- **Last updated:** 2017-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02307838

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02307838, "Long-term Follow-up of Fingolimod Phase II Study Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02307838. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*